OrthoPediatrics corp (KIDS)

NASD · Healthcare · Medical Devices · USA

OrthoPediatrics corp is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.

OrthoPediatrics designs and markets medical devices and bracing systems for pediatric orthopedic patients, including products for trauma correction, scoliosis and sports medicine applications. The company sells to hospitals and medical facilities worldwide through direct representatives and independent distributors, and operates orthotic and prosthetic clinics.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the OrthoPediatrics corp stock.

Our verdict on KIDS

Overvalued: intrinsic value $13.43 per share, market price $31.41, margin of safety -133.9% (as of 2026-11-17).

A 1.6x revenue multiple, discounted for its losses, values the shares at $13.43; the price of $31.41 is 134% above that value.

ETFs with the most weight in KIDS

17 more funds hold it; the full list is part of the paid plan.

More on KIDS

Browse

Peers in Medical Devices

All 140 Medical Devices stocks

Cheaper than KIDS in Medical Devices

39 more in this industry show a wider margin of safety.

Is KIDS undervalued or overvalued?

KIDS is overvalued (as of the 2026-11-17 close). A 1.6x revenue multiple, discounted for its losses, values the shares at $13.43; the price of $31.41 is 134% above that value.

What is the intrinsic value of KIDS?

$13.43 per share (as of the 2026-11-17 close), against a market price of $31.41. That is a margin of safety of -133.9%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.